ArticleOncogene2023
A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer.
Delong Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncogene2023
Delong Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.